Researchers observed that treatment was associated with changes in tendon healing parameters, including collagen fiber organization and biomechanical strength, as well as increased growth hormone receptor expression at the injury site [2]
Hes a former NCAA Division I wrestler and a self-described meathead in the gym, but with a focus on health. He cautions: I would never personally take or suggest anyone take any of these peptides without clear clinical evidence for benefit in treating a disease, he says
Many patients see meaningful improvement in the first 24 weeks without any lab work
Call VIVAA at 425-250-9999 for more information on the suitability of a Vitamin B12 injection.
In its lawsuit, the OFA said that the FDAs decision to end the shortage was a reckless and arbitrary move and could deprive patients of a vital treatment for type 2 diabetes and obesity. In an interview with BioSpace last month, David Rosen, partner at Foley & Lardner, said that the lawsuit is a precedent in this area. Prior to the OFA suit, no one has ever challenged the FDAs decision to remove a therapy from the drug shortage list. The OFA case is still ongoing, with the next court update due on Thursday
